TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9542398

Group type: EXPERIMENTAL
Intervention: Immunological rehabilitation through various therapeutic methods including drugs, plasmapheresis, hemosorption, electrophoresis, ultrasound.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta‐1‐trophoblastic glycoprotein in experiments.
Number of subjects: 0
Study: 8001095

Group type: EXPERIMENTAL
Intervention: Nonionic low osmolar contrast agent (iomeprol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ionic contrast agent (meglumine diatrizoate)
Number of subjects: 30
Study: 3183633

Group type: EXPERIMENTAL
Intervention: Daily acyclovir chemosuppression for 1 year
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intermittent acyclovir therapy (placebo group)
Number of subjects: 46
Study: 15840666

Group type: EXPERIMENTAL
Intervention: THEO (theophylline) with loop diuretic (LD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal saline placebo (NS) with loop diuretic (LD)
Number of subjects: 18
Study: 31599810

Group type: EXPERIMENTAL
Intervention: 0.04% polyhexanide
Number of subjects: 393

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Preoperative anemia
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: More than 5 prior abdominal operations
Number of subjects: 393
Study: 31163106

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/d and EPA 2 g/d
Number of subjects: 144

Group type: COMPARATOR
Intervention: Sertraline 50 mg/d and corn oil placebo
Number of subjects: 144
Study: 28855697

Group type: COMPARATOR
Intervention: Whey
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lactalbumin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lactoferrin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control
Number of subjects: 5
Study: 26220802

Group type: EXPERIMENTAL
Intervention: Daily electronic self-monitoring using smartphones for 6 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: Normal communicative purposes using smartphones for 6 months (Control)
Number of subjects: 78
Study: 23171529

Group type: EXPERIMENTAL
Intervention: BW group
Number of subjects: 233

Group type: COMPARATOR
Intervention: BW-BMI group
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 233
Study: 21704290

Group type: EXPERIMENTAL
Intervention: Iodine-based skin preparations followed by a cyanoacrylate-based skin sealant
Number of subjects: 300

Group type: COMPARATOR
Intervention: Skin preparations alone
Number of subjects: 300
Study: 19254970

Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation at 4 mL/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation at 5 mL/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Volume-targeted ventilation at 6 mL/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline (no volume targeting)
Number of subjects: 20
Study: 16730188

Group type: EXPERIMENTAL
Intervention: Silzone valve
Number of subjects: 403

Group type: COMPARATOR
Intervention: Control valve
Number of subjects: 403
Study: 15299052

Group type: EXPERIMENTAL
Intervention: Perfusable tissue index (PTI) in DCM patients
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Coefficient of variation of PTI in DCM patients
Number of subjects: 15
Study: 11291971

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 175

Group type: COMPARATOR
Intervention: Vitamin E 400 units/day
Number of subjects: 175

Group type: COMPARATOR
Intervention: Vitamin C 1,000 mg
Number of subjects: 175

Group type: COMPARATOR
Intervention: Vitamin A 25,000 IU
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: 400 gm of fruit daily
Number of subjects: 175
Study: 9253564

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 22

Group type: COMPARATOR
Intervention: Patient controlled analgesia with morphine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Remifentanil post-operative infusion
Number of subjects: 22
Study: 8309924

Group type: EXPERIMENTAL
Intervention: VRP1 Desitin
Number of subjects: 51

Group type: COMPARATOR
Intervention: Concomitant respiratory physiotherapy
Number of subjects: 51
Study: 3755348

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.8 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Papaveretum i.v. (control group)
Number of subjects: 10
Study: 30218318

Group type: EXPERIMENTAL
Intervention: Self-reported monthly non-adherence (ring ever out, out for ≥12 hours)
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Self-rating scale assessing ability to keep the vaginal ring inserted
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Composite measure of non-adherence (plasma DPV value ≤95 pg/ml and residual ring ≥23.5 mg)
Number of subjects: 1211
Study: 29421817

Group type: EXPERIMENTAL
Intervention: STW 5 (Iberogast)
Number of subjects: 980
Study: 26908964

Group type: EXPERIMENTAL
Intervention: Delamanid, a new drug for the treatment of multidrug-resistant tuberculosis.
Number of subjects: 17
Study: 25465642

Group type: EXPERIMENTAL
Intervention: Breathlessness support service
Number of subjects: 105

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105
Study: 22951761

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation
Number of subjects: 49

Group type: COMPARATOR
Intervention: Center-based rehabilitation
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 49
Study: 19297246

Group type: EXPERIMENTAL
Intervention: Essential oil gargle (2 drops of a 1:1 mix of manuka and kanuka essential oils in water)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (gargling with water)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control ('usual care')
Number of subjects: 19
Study: 17492425

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (100 ml whisky, approximately 32 g alcohol daily for 4 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption
Number of subjects: 19
Study: 15726874

Group type: EXPERIMENTAL
Intervention: Talinolol 200 mg once daily
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Talinolol 300 mg once daily
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Talinolol 100 mg once daily
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 11430849

Group type: EXPERIMENTAL
Intervention: High-risk family study
Number of subjects: 0
Study: 9678319

Group type: EXPERIMENTAL
Intervention: APOE epsilon4 genotype (APOE epsilon4/4)
Number of subjects: 28
Study: 7985595

Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 2532533

Group type: EXPERIMENTAL
Intervention: Mivacurium infusion during halothane anaesthesia
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Mivacurium infusion during opioid anaesthesia
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Recovery index for all patients after discontinuing the infusion
Number of subjects: 28
Study: 4913785

Group type: EXPERIMENTAL
Intervention: Nitrazepam (5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrazepam (10 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (100 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31103109

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan training (6 weeks, 18 sessions, 60 minutes each)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study: 29036257

Group type: EXPERIMENTAL
Intervention: Topical DNA repair enzyme lotion applied twice daily for 8 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (Eucerin Professional lotion) applied twice daily for 8 weeks
Number of subjects: 15
Study: 25886894

Group type: EXPERIMENTAL
Intervention: Standing work (SW)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 32
Study: 23333022

Group type: EXPERIMENTAL
Intervention: Daily Cone Beam Computed Tomography (CBCT)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Daily Electronic Portal Imaging with Fiducial Markers (EPI-FM)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Weekly controls (CBCT and EPI-FM)
Number of subjects: 208
Study: 21256073

Group type: EXPERIMENTAL
Intervention: Specific treatment based on the Movement System Impairment (MSI) model
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-Specific treatment
Number of subjects: 32
Study: 19762766

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Levobupivacaine/Bupivacaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Ropivacaine/Bupivacaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Ropivacaine/Levobupivacaine
Number of subjects: 75
Study: 18175830

Group type: EXPERIMENTAL
Intervention: Local phototherapy (one-time treatment)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pulse current exposure (2-3 times a week for 30-40 minutes)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 36
Study: 15180615

Group type: EXPERIMENTAL
Intervention: Greater alcohol intake
Number of subjects: 34694

Group type: EXPERIMENTAL
Intervention: Current tobacco use
Number of subjects: 34694
Study: 15682975

Group type: EXPERIMENTAL
Intervention: Single dose of rifampicin for chemoprophylaxis
Number of subjects: 21867

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21867
Study: 10510918

Group type: EXPERIMENTAL
Intervention: 10 mg morphine sulfate (MS)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 60 mg ketorolac tromethamine (KT)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Topical 2.5% lidocaine/prilocaine gel (Emla)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Ureteral stents (n = 32)
Number of subjects: 74
Study: 7856707

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel
Number of subjects: 66

Group type: COMPARATOR
Intervention: Foley catheter
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 1883120

Group type: EXPERIMENTAL
Intervention: Enalapril plus conventional antihypertensives
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo plus conventional antihypertensives
Number of subjects: 73
Study: 6455463

Group type: EXPERIMENTAL
Intervention: Nuva-Seal
Number of subjects: 220

Group type: COMPARATOR
Intervention: Delton
Number of subjects: 220
Study: 31085814

Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 30171915

Group type: EXPERIMENTAL
Intervention: Anodal stimulation over the right inferior frontal gyrus (rIFG) with cathodal stimulation over the left IFG
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study: 26724841

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3090

Group type: COMPARATOR
Intervention: 0.5 mg of dutasteride
Number of subjects: 3090
Study: 24630937

Group type: EXPERIMENTAL
Intervention: Vignette describing late blight
Number of subjects: 859

Group type: COMPARATOR
Intervention: Vignette about generic crop disease
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Perceived risks of GM to human and environmental health
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Perceived benefits of GM (e.g. reduced threats to crops and a more secure food supply)
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Objective knowledge about GM
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Self‐assessed familiarity with GM
Number of subjects: 859
Study: 22466467

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine with 75 IU of hyaluronidase as peribulbar injection of 5 mL before surgery
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine with 75 IU of hyaluronidase as peribulbar injection of 1 mL or 3 mL before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (30 patients without any additional analgesic treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine with 75 IU of hyaluronidase as peribulbar injection of 5 mL after surgery
Number of subjects: 60
Study: 20138043

Group type: EXPERIMENTAL
Intervention: Capsule endoscopy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Dedicated small bowel radiography
Number of subjects: 136
Study: 18039077

Group type: EXPERIMENTAL
Intervention: High-loading dose regimen of liposomal amphotericin B (L‐AMB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dosing regimen of liposomal amphotericin B (L‐AMB)
Number of subjects: 0
Study: 16082239

Group type: EXPERIMENTAL
Intervention: Kangaroo Care (skin‐to‐skin contact) during heel stick
Number of subjects: 24

Group type: COMPARATOR
Intervention: Heel stick in the warmer
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Kangaroo Care (skin‐to‐skin contact)
Number of subjects: 24
Study: 12124952

Group type: EXPERIMENTAL
Intervention: Intra-atrial infusion of heparin and tissue plasminogen activator (t-PA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Heparin and streptokinase
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 30
Study: 10417578

Group type: EXPERIMENTAL
Intervention: 950 microsec dwell time CO2 laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baker's phenol
Number of subjects: 20
Study: 7483799

Group type: EXPERIMENTAL
Intervention: Three doses of oral poliomyelitis (OPV) and diphtheria and tetanus (DTV) vaccines
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Three doses of OPV and DTV vaccines plus recombinant hepatitis B vaccine (HBV)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: HBV recombinant vaccine alone
Number of subjects: 243
Study: 31567484

Group type: EXPERIMENTAL
Intervention: Electromyography-triggered neuromuscular electrical stimulation training (single electrical stimulation group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined electromyography-triggered neuromuscular electrical stimulation and tilt sensor functional electrical stimulation training (combined electrical stimulation group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 28187529

Group type: EXPERIMENTAL
Intervention: Timed Up & Go test (TUG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Knee extension strength
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strength asymmetry
Number of subjects: 0
Study: 25907146

Group type: EXPERIMENTAL
Intervention: Gastrocnemius stretching combined with joint mobilization
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gastrocnemius stretching alone
Number of subjects: 24
Study: 23244654

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention program for primary prevention of asthma applied during the first year of life
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Early-onset AD (16.6% prevalence during the first 2 years)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Late-onset AD (6.2% prevalence after age 2)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Persistent AD
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Early-onset AD (persistent or nonpersistent)
Number of subjects: 373
Study: 21498489

Group type: EXPERIMENTAL
Intervention: Immobilization in internal rotation for three weeks
Number of subjects: 188

Group type: COMPARATOR
Intervention: Immobilization in external rotation for three weeks
Number of subjects: 188
Study: 19192030

Group type: EXPERIMENTAL
Intervention: Low-glycaemic index beverage
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (sucrose-based beverage)
Number of subjects: 6
Study: 16775229

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 to 400 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 15363423

Group type: EXPERIMENTAL
Intervention: rhBMP-2 on an absorbable collagen sponge
Number of subjects: 67

Group type: COMPARATOR
Intervention: Autogenous iliac crest bone graft
Number of subjects: 67
Study: 11293641

Group type: EXPERIMENTAL
Intervention: 250 mg erythromycin
Number of subjects: 6295

Group type: EXPERIMENTAL
Intervention: 325 mg co-amoxiclav (250 mg amoxicillin and 125 mg clavulanic acid)
Number of subjects: 6295

Group type: EXPERIMENTAL
Intervention: both antibiotics (erythromycin and co-amoxiclav)
Number of subjects: 6295

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6295
Study: 9048720

Group type: EXPERIMENTAL
Intervention: Type II fibre predominance in muscle biopsy
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Constant treadmill work load test
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Blood lactate measurement
Number of subjects: 37
Study: 15278789

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 27
Study: 3013123

Group type: EXPERIMENTAL
Intervention: Continuous absorbable suture (No. 2, coated, polyglycolic acid suture - Dexon‐Plus)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Interrupted nonabsorbable suture (No. 28 monofilament stainless steel wire)
Number of subjects: 105
Study: 31725608

Group type: EXPERIMENTAL
Intervention: Simulation of blindness using a sleep mask for 45 minutes, split into 3 periods of 15 minutes each.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal vision group (Group i)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual impairment group (Group ii)
Number of subjects: 0
Study: 28279371

Group type: EXPERIMENTAL
Intervention: High lipid content in carotid plaques
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Thin/ruptured fibrous cap in carotid plaques
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Intraplaque hemorrhage
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: High calcification content in carotid plaques
Number of subjects: 214
Study: 26047934

Group type: EXPERIMENTAL
Intervention: Tonsillectomy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 600
Study: 24006672

Group type: EXPERIMENTAL
Intervention: Suspended moxibustion
Number of subjects: 56

Group type: COMPARATOR
Intervention: Acupuncture (Control)
Number of subjects: 56
Study: 21530213

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-completers (both groups)
Number of subjects: 0
Study: 18070787

Group type: EXPERIMENTAL
Intervention: AirWay Scope (AWS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 45

Group type: COMPARATOR
Intervention: McCoy laryngoscope
Number of subjects: 45
Study: 18603947

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with combination of permanent and releasable scleral flap sutures (Group B)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional trabeculectomy (Group A)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 12585979

Group type: EXPERIMENTAL
Intervention: HSV-2 vaccine
Number of subjects: 10
Study: 11098556

Group type: EXPERIMENTAL
Intervention: FGF‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Heat-denatured growth factor (Control)
Number of subjects: 40
Study: 8703450

Group type: EXPERIMENTAL
Intervention: Epidural plus general anesthesia with TMP-induced hypotension for 50 minutes
Number of subjects: 42

Group type: COMPARATOR
Intervention: Epidural plus general anesthesia with SNP-induced hypotension
Number of subjects: 42

Group type: COMPARATOR
Intervention: General anesthesia with SNP-induced hypotension
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: General anesthesia with TMP-induced hypotension for 20 minutes
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Epidural plus general anesthesia with TMP-induced hypotension
Number of subjects: 42
Study: 1394809

Group type: EXPERIMENTAL
Intervention: Intravesical instillations of Adriamycin (ADM) at 20 mg/40 ml physiological saline for 2 years after TUR (Group A)
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Intravesical instillations of Adriamycin (ADM) at 20 mg/40 ml physiological saline for 2 weeks before TUR (Group B)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Control group undergoing TUR only (Group C)
Number of subjects: 443
Study: 3886004

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Magnesium trisilicate
Number of subjects: 36
Study: 29589416

Group type: EXPERIMENTAL
Intervention: Conscious sedation (awake/cooperative sedation)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Caregivers (main caregivers of patients)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Caregivers (other ICU patients not enrolled in the study)
Number of subjects: 29

Group type: COMPARATOR
Intervention: ICU staff (nurses, attending physicians, residents, medical students)
Number of subjects: 29
Study: 28965100

Group type: EXPERIMENTAL
Intervention: Oral resveratrol, 40 mg (two caplets) two times per day for 1 week, then 20 mg (one caplet) two times per day for a total of 6 months
Number of subjects: 164

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Oral resveratrol
Number of subjects: 164
Study: 26296556

Group type: EXPERIMENTAL
Intervention: Intensive, multicomponent lifestyle interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pragmatic design assessment using the PRECIS tool
Number of subjects: 0
Study: 23948785

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (1000-3000 mg daily) plus α-lipoic acid (600-1800 mg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21615419

Group type: EXPERIMENTAL
Intervention: Testosterone (1000mg intramuscular long-acting testosterone undecanoate)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (33μg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (saline for men, matching placebo for women)
Number of subjects: 84
Study: 18329882

Group type: EXPERIMENTAL
Intervention: Porous coated prosthesis with solution-deposited HA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prosthesis without HA
Number of subjects: 60